The largest database of trusted experimental protocols

Recombinant human fgf

Manufactured by R&D Systems

Recombinant Human FGF is a laboratory product that contains the Fibroblast Growth Factor (FGF) protein, which is produced through recombinant DNA technology. FGF is a signaling protein involved in various biological processes, including cell growth, differentiation, and angiogenesis. This product can be used for research purposes in the study of FGF and its functions.

Automatically generated - may contain errors

2 protocols using recombinant human fgf

1

Cultivation of Mesenchymal Stem Cells from Diverse Sources

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCPat cells (MSC7-BJ), human primary BMSCs, derived from bone marrow aspirates previously described in (23 (link)) and hMPCs described in (24 (link)) were cultured in αMEM supplemented with 10% MSC-FBS (12662029; Life Technologies), Glutamine 10mM (Life Technologies) and 2 ng/mL Recombinant Human FGF (233-FB-025; R&D Systems). For these primary cells, written informed consent was obtained according to the Declaration of Helsinki and studies were approved by the ethics committees of the contributing institutions. A673 were cultured in DMEM medium supplemented with 10% FBS (Life Technologies) and cultured at 37 °C in a humidified atmosphere with 5% CO2 and 20% O2. MSCPat and hMPCs were cultured in hypoxic-like conditions (3% O2). Culture cells were tested monthly for mycoplasma contamination (with the VenorGeM qEP kit (11-9250, Minerva Biolabs), and if positive, cells were treated with the mycoplasma treatment kit (Myco-1&2 set A8360.0010, VWR). MSCPat were culture at low passages (up to 10). EWIma clones were kept in culture from passage 1 and up to 100 days in culture. Cells used in the study are fully described in Supplementary Materials.
+ Open protocol
+ Expand
2

Isolation and Culture of Mouse Adipose Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ASCs were isolated from mouse subcutaneous, abdominal, and perivascular adipose tissue, as described previously (Gu et al., 2019 (link)). Briefly, adipose tissue was cut into 1-mm3 small pieces, which was then digested with 2 mg/mL collagenase type I (Gibco) and 1 mg/mL Dispase II (Sigma) in Hanks’ balanced salt solution (HBSS) at 37°C for 30–45 min with occasional vortex. The digestion was stopped by DMEM/F12 with 10% FBS and subsequently passed through a 100-μm filter followed by a centrifugation at 300 g for 5 min. Cell precipitates were resuspended in a stem cell culture medium as the following: Minimal Essential Medium-α (Gibco) with 15% fetal bovine serum (Gibco), 10 ng/mL recombinant human leukemia inhibitory factor (Sigma), 5 ng/mL recombinant human FGF (R&D), 2 mmol/L L-glutamine (Sigma), 100 U/mL penicillin, and 100 mg/mL streptomycin (Gibco); they were then incubated in a 5% CO2 incubator. The cells were passaged at a ratio of 1:3 every 2 or 3 days. The medium was refreshed every 2 days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!